ECLIA法与RRA法检测血清促甲状腺激素受体抗体的对比研究被引量：5

Comparative Study of the Detection of Serum Thyrotrophic Receptor Antibody by ECLIA and RRA

下载PDF

导出

摘要目的探讨ECLIA检测TRAb的可行性和实用性。方法采用德国罗氏全自动电化学发光免疫分析法(ECLIA)与实验室常规检测TRAb的放射受体分析法(RRA)这两种方法同时检测血清促甲状腺激素受体抗体(TRAB)含量,共检测血清样本317份,其中甲状腺功能亢进患者159例,健康者158例。结果 ECLIA检测TRAb数值与RRA有显著差异(P<0.01),但与RRA检测值整体相关(r=0.792,P<0.01)。取各自正常参考值上限后,两种方法诊断符合率为86.0%,分类一致性Kappa值为0.896(P>0.05)。结论 ECLIA检测TRAb在精密度方面良好,且操作简便,检测速度快。 Objectiive To explore the feasibility and clinical practicalities of electrochemilluminescence immunoassay（ECILA） for the measurement of serum thyrotrophic receptor antibody（TRAb）.Methods The serum TRAb levels in 159 patients with hyperthyroid and 158 health controls were measured by both ECILA and Radiorecptor Assay（RRA）.Results Results showed that there was a significant difference in TRAb values measured by two immunoassay methods（P〈0.01）.By given the upper limit of nomal values,the diagnostic coincidence rate between twomethods was 86% with Kappa value 0.896.Conclusion The serum thyrotrophic receptor antibody assay with ECLIA exhibits a intra-assay precision as well as easier operation and faster procedures.

作者彭鸣亚徐龙宝邓民斌薄静莉杨其贤

机构地区常州市第二人民医院核医学科

出处《中国医药指南》 2011年第20期186-187,共2页 Guide of China Medicine

关键词促甲状腺素受体抗体 GRAVES病 ECLIA Serum thyrotrophic receptor antibody Graves＇ disease ECLIA

分类号 R581.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献4

1Sehott M,Hermsen D,Broecker-Preuss M,et al.Clinical value of the first at Jtol/I,tlted TSH receptor a atoantibody assay for the diagnosis of Groves' disease(GD):an international muhieentre tRRAI[J].Clin Endocrinol,2009,71 (8):566-573.
2周亚芹,苏青.促甲状腺素受体抗体的检测方法(文献综述)[J].放射免疫学杂志,2009,22(1):40-43. 被引量：12
3Yoshimura NJ,Miyazaki N,Ito K,et a l.Evaluation of a new rapid- and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibedies[J].Thyroid,2009,18(10): 1157- 1164.
4Hermsen D,Broecker-Preuss M,Casati M,et al.Technical evaluation of the firstfully automated assay for the detection of TSH receptor autoantibodies[J].Clinica Chemiea Acts,2009,40(1/2):84-89.

二级参考文献25

1兰玲,施秉银.促甲状腺素受体抗体检测的临床意义[J].国外医学（内分泌学分册）,2005,25(1):42-44. 被引量：12
2兰玲,施秉银.促甲状腺素受体抗体检测技术的回顾与展望[J].国外医学（内分泌学分册）,2005,25(1):45-47. 被引量：11
3Mizutori Y, Chen CR, MeLachlan SM, et al. The thyrotrepin receptor hinge region is not simply a scaffold for the Leueine - Rich Domain but contributes to ligand binding and signal transduction. Molecular Endocrinology. 2008,22(5) :1171.
4Kohn LD, Harii N. Thyrotropin receptor autoantibodies (TSHRAbs) : epitopes, origins and clinical significance. Autoimmunity. 2003,36(6 -7) :331.
5Morgenthaler NG, Ho SC, Minich WB. Stimulating and blocking TSH - receptor autoantibodies from patients with Graves's disease and antoimmune hypothyroidsm have very similar concentration, TSH - receptor affinity and binding sites. J Clin Endocrinol Metab. 2007,92(3 ) :1058.
6Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves's disease. J Clin Endocrinol Metab. 1999,84(1) :90.
7Villata D, Orunesu E, Tozzoli R, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotropin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol. 2004,57 (4) :378.
8Pedersen IB, Knudsen N, Perrild H, et al. TSH - receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goiter: a comparison of two competitive binding assays. Clin Endocrinol. 2001,55(3) :381.
9Massart C, Orgiazzi J, Maugendre D. Clinical vandity of a new commercial method for detection of TSH - receptor binding antibodies in sera from patients with Graves' disease treated with antithvroid drugs. Clin Chem Acta. 2001,304:39.
10Smith BR, Bolton J, Young S, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid. 2004,14 (10) : 830.